Lots of words but absolutely nothing useful that stroke survivors can make sense of and use.
http://www.ijamtes.org/gallery/44.aug%20ijmte%20%20-%20cw.pdf
Nasreena Sajjad
*
1
,
Rohaya Ali
1
,
Sumaya Hassan
1
1
(
Department of Biochemistry,
University of Kashmir, India)
*Corresponding author:
neersanrizvi@gmail.com
ABSTRACT
Polyphenols are common secondary metabolites in the plant kingdom; this diverse family of chemical compounds
has been extensively studied in pharmacology due to its high biomedical potential and abundance in vegetables and
fruits.
Within the last years, a rapidly growing number of polyphenolic compounds with neuroprotective effects have
been described. Many efforts have been made to explore the mechanisms behind the neuroprotective action of
polyphenols. However, many pathways and mechanisms considered for mediating these effects are rather
general
than specific. Moreover, despite the beneficial effects of polyphenols in experimental treatment of
neurodegeneration, little has been achieved in bringing them into routine clinical applications.
Among the
pharmacological activities attributed t
o natural polyphenols are antioxidant, anti
-
inflammatory, antibacterial,
anthelmintic, antidiabetic, antiaging and neuroprotective. Interestingly, recent clinical trials have confirmed, some of
the overwhelming in vitro pharmacological studies, especially
those describing orally administered polyphenols with
protective effect against metabolic and neurological diseases. Future studies on this latter area are the next frontier
towards expanding the current knowledge on the mode of action of plant
-
derived com
pounds, and their metabolites,
on human health.
Keywords:
Neurodegeneration, polyphenols, antioxidant, neuroprotection
I
. INTRODUCTION
Neurodegenerative diseases (ND)
include
Alzheimer’s (AD) and Parkinson’s disease (PD) and multiple sclerosis
(MS)
which
primarily affect the neurons in the human brain and are characterized by deterioration of neurons or
myelin sheath, sensory information transmission disruption
, movement control, and more
[1].
The greatest risk
factor for ND is aging, which carries mitoc
hondrial dysfunction, chronic immune
-
inflammatory respo
nse, and
oxidative stress
, the major caus
es of neuronal damage and death [2].
Nowadays, ND are chronic and incurable
conditions whose disabling effects may continue for years or even decades representi
ng an enormous disease load,
regarding human suffering and economic cost.
Dietary
genetic
, and molecular factors
are important determinants in
progression and intervention of neurodege
nerative diseases [3].
The ND are more common and have a
disproportionat
e impact on countries with longer life expectancies and represent the fourth highest source of overall
disease burden in the
high
-
income countries.
Plant secondary metabolites are one of the most important sources of
therapeutic drugs and
in fact
many drug
s currently in use are
derived from plants.
Recently, a
number
of natural
International Journal of Management, Technology And Engineering
Volume 8, Issue VIII, AUGUST/2018
ISSN NO : 2249-7455
Page No:368
medicinal plants have been tested for their therapeutic properties, showing that the raw extracts or isolated pure compounds from them have more effective properties than the whole p
lant as an alternative for the treatment of ND
[
4
].
These properties are due mainly to the presence of polyphenols
alkaloids, and terpenes,
among others, that are
micronutrients produced by plants
as secondary metabolites
. There is substantial evidence (epidemiological studies,
animal studies, and human clinical trials) that indicates that polyphenols reduce a wide range of pathologies [
5
].
II
.
POLYPHENOLS
Natural polyphenols are
most
commonly found chemical compounds in
consumed
h
erbal beverage and food
.
T
hey
constitute a large group of
phytochemicals
with more than 8000 identified compounds [6
].
The primary function of
these
compounds
is
protection of plants against reactive oxygen species (ROS), produced during photosynthesis, and
consumption by herbivo
res
.
Within the previous decades, most of
the
studies on polyphenols have been focused on
anti
-
oxidant properties.
Along with introducing resveratrol, as
a
potential anti
-
aging agent, much focus has been
placed on protective effects of
various
polyphenols
against aging and related
neurodeg<
enerative disease.
Increase in
life
span
by polyphenols can be associated with increased or improved brain function. For instance, epigallocatechin
gallate (EGCG) postponed the onset of neurological symptoms and prolonged
life span in a
mice model of
amyotrophic lateral sclerosis
(ALS)
[
7
].
Long term treatment with epigallocatechin gallate increased the life span
and
enhanced
movement abilities in a transgenic Drosophila melanogaster model of
Parkinson’s disease
(
PD
)
[
8
].
Despite the
prominent evidence of neuroprotective effects of polyphenols from in vitro and
preclinical
models,
overall
success
in
bringing
these
compounds
into
routine
clinical
application
has
been
limited.
Polyphenols exhibit
strong potential to address the etiology of neurological disorders as they
,
attenuate their complex physiology by
modulating several therapeutic targets at once
[
9
].
In particular, signaling pathways like PPAR, Nrf2, STAT, HIF,
and MAPK along with modulation of immune response by polyphenols are e
valuated by various
studies[
10
].
Although current polyphenol researches have limited impact on clinical practice, they have strong
evidence and testable hypothesis to contribute clinical advances and drug discovery towards age
-
related neurologic
al
disorders.
The main mechanisms of polyphenols include their well
-
characterized antioxidant effects
, inhibition of intracellular
kinases activity,
binding to cell surface receptors
, and modifying cell membrane functions
.
A number of in
vivo and
in vitro
studies have
shown that polyphenol c
atechins from green tea extract
possess a protective
role in
neurodegeneration
[
11
].
Pre
treatment with the flavonoid epicatechin attenuated
neurotoxicity induced by oxidized
low
-
density lipopro
tein in
mouse
-
derived striatal
neurons
, as
evidenced by apoptotic DNA fragmentation and
caspase
-
3 activation. Catechin conferred a similar protection to primary culture of mesencephalic neurons
challenged
with 6
-
hydroxydopamine (6
-
OHDA)
[
12
].
Tea catechins are powerful
hydrogen
-
donating antioxidants
and free radical scavengers of reactive oxygen and nitrogen species in a number of in vitro systems. They have also
been shown to inhibit lipid peroxidation induced by iron
ascorbate in homogenates of
brain mitochondrial >
membranes and brain synaptosomes
.
Green tea polyphenols have been found to be more effective antioxidants than
vitamins E and C on a molar basis, as
indicated
by their reduction potentials
.
In addition
to their radical scavenging
action, green tea catechins
possess well
-
established metal
-
chelating properties.
International Journal of Management, Technology And Engineering
Volume 8, Issue VIII, AUGUST/2018
ISSN NO : 2249-7455
Page No:369Furthermore, it has been shown that a number of flavonoids and phenolic antioxidants activate the expression
of
some stress
-
response genes, such as phase II drug
-
metabolizing enzymes, glutathione S
-
transferase, and
heme
-
oxygenase 1, probably via their binding to
the antioxidant regulatory element (ARE) present in the
promoter of their
respective genes [
13
].
Additionally, the
transcriptional activation
of these stress
-
response genes
correlated with an
increase in the
activity and nuclear
binding of the transcription factors Nrf1
and Nrf2 to the
ARE sequences
contained
in their promoters via
activation of the MAPK pathway.
Resveratrol, a polyphenol abundant in grapes and red wines,
[14]
inhibited Aβ 42 fibril formation
and protected
from Aβ neurotoxicity by inhibiting inducible nitric oxide synthase inhibition
.
Resveratrol, with possibly high
bioavailability in lipid core nanocapsules, exhibited therapeutic action in AD
[15]
. Rutin has been found to control
oxidative stress, malondialdehyde, and glutathione disulfide formation
in SH
-
SY5Y neuroblastoma cells [16].
Rutin
has also attenuated the inflammatory cascade by decreasing cytokines like TNF
-
α and IL
-
1β
. Ferulic acid, a phenolic
acid, has also exhibited higher neuroprotection against
Aβ toxicity than
quercetin
[
17
].
Recent research findings
have shown that polyphenols have therapeutic relevance in both cell and animal model studies. The ability of polyphenols to improve synaptic transmission by elevating cAMP, target multiple signaling pathways, and reduce
Aβ toxicity suggests their therapeutic utility for age
-
related
disorders like AD and dementia
.
Epigallocatechin
-
3
-
gallate (EGCG) exhibited neuroprotective effects by modulating neuroinflammation an
d attenuating neural
damage.
Quercetin, apple polyphenols
,
myricetin
have also activated SIRT1, thus exhibiting potential in MS treatment
[
18
].
Polyphenols with their ability to attenuate oxidative stress and inflammation present therapeutic opti
on in
neurodegenerative diseas
e.
Other pol>
yphenols such as baicalein, kaempferol, caffeic acid,
and
EGCG
have been
shown to extend neuroprotection in PD studies. Similarly, polyphenolic extracts from various plants have also exhibited pharmacological
role in PD studies.
III
No comments:
Post a Comment